Lapatinib and renal cell carcinoma

By Gross-Goupil Marine   Bernhard Jean-Christophe   Ravaud Alain  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 11, 2012-11 ,pp. : 1727-1732

Informa Healthcare

Access to resources Recommend Favorite

A randomized phase II trial of interleukin-2 in combination with four different doses of bryostatin-1 in patients with renal cell carcinoma

By Peterson Amy   Harlin Helena   Karrison Theodore   Vogelzang Nicholas   Knost James   Kugler John   Lester Eric   Vokes Everett   Gajewski Thomas   Stadler Walter  

Investigational New Drugs, Vol. 24, Iss. 2, 2006-03 ,pp. : 141-149

Springer Publishing Company

Access to resources Recommend Favorite

Everolimus: In Advanced Renal Cell Carcinoma

By Garnock-Jones Karly P.   Keating Gillian M.  

Drugs, Vol. 69, Iss. 15, 2009-10 ,pp. : 2115-2124

Adis International

Access to resources Recommend Favorite

Emerging drugs for renal cell carcinoma

By Varella Leticia   Rini Brian I  

Expert Opinion on Emerging Drugs, Vol. 15, Iss. 3, 2010-09 ,pp. : 343-353

Informa Healthcare

Access to resources Recommend Favorite

Adjuvant treatment for renal cell carcinoma

By Lam John S   Belldegrun Arie S   Figlin Robert A  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 6, 2006-04 ,pp. : 705-720

Informa Healthcare

Access to resources Recommend Favorite